Amino Acid Fingerprint in Blood Reveals Who Escapes Fatty Liver Disease

A striking pattern of essential amino acids circulating in the blood may help determine who develops fatty liver disease and who recovers from it, according to a large prospective study published in BMC Medicine. Researchers led by Zilong Lu, Kejun Zhou, Manjing Cheng and Yu-ming Chen, drawing on the twelve-year Guangzhou Nutrition and Health Study and validating their findings in nearly half a million UK Biobank participants, report that a serum signature defined by higher levels of methionine and threonine alongside lower levels of the branched-chain amino acids valine, leucine and isoleucine was associated with both a substantially lower risk of developing metabolic dysfunction–associated steatotic liver disease, or MASLD, and a greater likelihood of recovering from it. The finding offers one of the most detailed pictures yet of how the body’s amino acid economy tracks with one of the world’s most common liver conditions.

MASLD, the modern name for what was long called non-alcoholic fatty liver disease, is defined by the accumulation of fat in liver cells in the presence of overweight, insulin resistance or other cardiometabolic risk factors. It affects an estimated three in ten adults globally and can progress to inflammation, fibrosis and cirrhosis, yet there are no approved pharmacological therapies for the majority of patients, and management rests on diet, exercise and weight loss. Because the disease develops silently over years, researchers have increasingly turned to metabolomics, the systematic measurement of small molecules in blood, to find early warning signs and, ideally, modifiable targets. Circulating amino acids have repeatedly surfaced in such studies, but individual metabolites fluctuate with meals, genetics and physiology, making it difficult to know which combinations actually matter for disease trajectories.

The new study took a pattern-based approach. Rather than asking whether any single amino acid predicts liver fat, the team used principal component analysis, a statistical technique that compresses many correlated variables into a small number of composite scores, to derive patterns from targeted metabolomic measurements of serum essential amino acids. Essential amino acids are those the human body cannot synthesize and must obtain from food: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine. Because they come from the diet yet are heavily processed by the liver and by gut microbes, their circulating levels sit at a biological crossroads between what a person eats, how their metabolism handles it, and how their liver is functioning.

The discovery cohort comprised 867 participants of the Guangzhou Nutrition and Health Study who had targeted metabolomics available at baseline and at follow-up visits two through four. MASLD status was assessed across follow-ups one to four, deliberately excluding baseline so that the analysis could capture new disease onset rather than prevalent cases. From metabolite levels averaged across visits, the researchers derived an incidence-oriented essential amino acid pattern score. Participants with a pattern characterized by relatively higher methionine and threonine and relatively lower valine, leucine and isoleucine had a markedly lower risk of developing MASLD: the standardized hazard ratio was 0.61, with a 95 percent confidence interval of 0.51 to 0.73. In other words, across the distribution of the pattern score, those at the favorable end faced roughly 39 percent lower hazard of incident disease than those at the unfavorable end.

Crucially, the same pattern told a story about recovery. Among participants who had MASLD during the study, a recovery-oriented pattern score was associated with significantly greater odds of the disease resolving, with a standardized estimate of 2.06 and a 95 percent confidence interval of 1.67 to 2.53. The team also constructed a combined pattern score and a recovery-derived score, and the associations held. To guard against the possibility that the discovery result was a statistical fluke of one cohort, the researchers validated the pattern in 1,623 additional participants from the same Guangzhou study and then externally in 481,982 participants of the UK Biobank, a vast biomedical database of British adults. The direction and magnitude of the associations were consistent across these independent populations, lending considerable weight to the conclusion that the amino acid signature is not an artifact of a single Chinese cohort.

What might explain the biology? The investigators identified thirteen metabolites related to the favorable essential amino acid pattern that appeared to partly mediate, or statistically account for, the association between the pattern and MASLD outcomes. Among them were key intermediates of the tricarboxylic acid cycle, the Krebs cycle that sits at the heart of cellular energy metabolism: pyruvic acid, isocitric acid and oxoglutaric acid. This is mechanistically coherent. Branched-chain amino acids, which are catabolized heavily in muscle and liver, feed carbon into central energy metabolism, and chronically elevated circulating branched-chain amino acids have long been associated with insulin resistance and hepatic fat accumulation. Methionine, by contrast, is central to one-carbon metabolism and the synthesis of S-adenosylmethionine, a molecule involved in phosphatidylcholine production and very-low-density lipoprotein export from the liver, while threonine is a substrate for glycine and serine synthesis and for mucin production in the gut. A pattern favoring methionine and threonine over branched-chain amino acids may therefore reflect a metabolic state in which hepatic fat handling and mitochondrial energy flux are better balanced.

The mediation analysis, conducted with false discovery rate control and a significance threshold of P less than 0.05, suggests that the TCA cycle intermediates and related metabolites carry part, though not all, of the association. The authors are careful on this point: the metabolites may partly account for the amino acid pattern’s relationship with MASLD, but the data cannot prove that manipulating amino acid levels would directly change liver fat. Serum amino acids are themselves influenced by diet, insulin action, kidney function and the gut microbiome, so the pattern may be best understood as a circulating metabolic signature, an integrated readout of metabolic health, rather than a simple causal lever.

That said, the study did find that the favorable pattern travels with modifiable behavior. Using food frequency questionnaires and validated indices, the researchers showed that a healthy diet and lifestyle were positively associated with the beneficial essential amino acid pattern. Higher scores on measures such as the Alternate Mediterranean Diet Score, the Dietary Approaches to Stop Hypertension score, the healthful plant-based diet index and overall dietary diversity were linked to the pattern characterized by higher methionine and threonine and lower branched-chain amino acids. This is an important bridge from biomarker to action: it suggests that the kinds of diets already recommended for cardiometabolic health, rich in plant foods, whole grains and diverse protein sources, are associated with the amino acid profile that tracks with lower MASLD risk and better recovery.

The implications for prevention are tantalizing but must be framed with appropriate caution. Branched-chain amino acids are abundant in animal protein and whey supplements, and their elevation in obesity is thought to reflect both intake and impaired catabolism. The study does not suggest that people should avoid protein or seek out methionine and threonine supplements; indeed, the authors explicitly state that the pattern’s clinical utility requires further validation before it can inform practice. What the work does provide is a candidate biomarker that could, with future research, help stratify risk, monitor response to lifestyle intervention, and guide the design of nutritional trials. A blood test that captures an integrated amino acid signature could eventually complement ultrasound and liver enzyme panels in identifying who is drifting toward fatty liver years before disease becomes detectable by conventional means.

The scale and design of the study set it apart from much of the prior metabolomics literature. Twelve years of follow-up across five visits in the Guangzhou cohort allowed the researchers to separate incidence from recovery, two outcomes that many cross-sectional studies conflate. The external validation in the UK Biobank, spanning a different ancestry, diet and health system, addresses one of the most persistent weaknesses of metabolomic biomarker research, which is overfitting to the population in which a signature was discovered. Funded by the National Natural Science Foundation of China and the 5010 Program for Clinical Research of Sun Yat-sen University, the work exemplifies a growing trend of rigorous, pattern-level metabolomic epidemiology. As MASLD continues its rise in parallel with obesity and diabetes worldwide, the search for early, modifiable metabolic signatures has become a public health priority. This study’s essential amino acid pattern, anchored in the biochemistry of the Krebs cycle and associated with healthy diets, offers a promising thread to pull, and future intervention studies will determine whether shifting this signature through diet and lifestyle can genuinely bend the curve of the global fatty liver epidemic.

Subject of Research: Serum essential amino acid patterns and their association with incidence and recovery of metabolic dysfunction–associated steatotic liver disease

Article Title: Identifying serum essential amino acid patterns protective against the incidence and conducive to the recovery of metabolic dysfunction–associated steatotic liver disease: a prospective cohort study

Article References: Lu, Z., Zhou, K., Cheng, M., Mamuti, R., Zhou, F., Huang, F., Xi, Y., Deng, K., Xu, L., Wang, J., Xie, G., & Chen, Y.-M. (2026). Identifying serum essential amino acid patterns protective against the incidence and conducive to the recovery of metabolic dysfunction–associated steatotic liver disease: a prospective cohort study. BMC Medicine. https://doi.org/10.1186/s12916-026-05201-3

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05201-3

Keywords: MASLD, essential amino acids, branched-chain amino acids, methionine, threonine, metabolomics, TCA cycle, prospective cohort, UK Biobank, fatty liver disease, nutrition, Guangzhou Nutrition and Health Study